Sign In to Follow Application
View All Documents & Correspondence

Process For Preparing Bisphospholane Ligands

Abstract: The present invention is directed at a process for preparing enantiomerically enriched compounds of the general formula (I). Compounds of the type shown are employed in catalyst systems.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 April 2006
Publication Number
16/2007
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

DEGUSSA AG
BENNIGSENPLATZ 1, 40474 DUSSELDORF,

Inventors

1. DR.THOMAS RIEREIER
FINKENWEG 8, 61130 NIDDERAU-OSTHEIM
2. DR. AXEL MONSEES
FALKSTRASE 46, 60487 FRANKFURT
3. DR. JUAN JOSE ALMENA PEREA
SALISWEG 30B, 63454 HANAU
4. DR. RENAT KADYROV
WALTER-HESSELBACH-STRASSE 190, 60389 FRANKFURT
5. DR. BATTSENGEL GOTOV
ZUUNKHARAA TRADE CO., LTD., CHINGISS AVENUE, KHAN-UUL DISTRICT 1, ULAANBAATAR, CITIZEN OF MONGOLIA
6. DR. WERNER ZEIB
AM ANGER 2A, 82547 EURASBURG
7. DR. IRIS NAGL
DRACHENSEESTRASSE 6, 81373 MUNCHEN
8. PROF. ARMIN BORNER
IM WINKEL 40, 18055 ROSTOCK,
9. DR. JENS HOLZ
ALT-ROGGENTINER WEG 14, 18196 KESSIN
10. PROF. KARLHEINZ DRAUZ
ZUR MARIENRUHE 13, 63579 FREIGERICHT
11. WILFRIED MEICHELBOCK
ALBRECHT-DURER-STRASSE 25, 82152 KRALLING

Specification

WO 2005/049629 PCT/EP2004/012279
1
Process for preparing bisphospholane ligands
The present invention is directed at a process for the preparation of bidentate ligands based on bisphospholanes. In particular, the invention relates to the preparation of enantiomerically enriched compounds of the general formula (I) :

Enantiomerically enriched ligands are used in asymmetric synthesis or asymmetric catalysis. The important thing here is that the electronic and stereochemical properties of the ligand are optimally matched to the respective catalysis problem. An important aspect of the success of this class of compounds is believed to be the creation of an asymmetric environment around the metal centre due to these ligand systems. To utilize such an environment for
effective transfer of the chirality, it is advantageous to control the flexibility of the ligand system as inherent limitation of the asymmetric induction.
Within the class of phosphorus-containing ligands, cyclic phosphines, in particular phospholanes, have attained particular importance. Bidentate, chiral phospholanes are, for- example, the DuPhos and BPE ligands used in asymmetric catalysis. In the ideal case, these provide a chiral ligand framework which can be modified in a variety of ways and can be varied within a broad range in terms of its steric and electronic properties.

WO 2005/049629 PCT/EP2004/017779
2
DE10309356 describes concrete ligand systems and a route for preparing them. The synthetic route presented there starts out from phenylphosphine which is converted into a dimetal phenolphosphine by deprotonation with a strong base before the reaction to form the phospholane is carried out.
EP528865 describes the preparation of phospholanes starting from dilithiophenylphosphine and a bifunctional alkylation reagent. The preparation of the dilithioplaenylphosphine is not mentioned.
EP1028967, JOC 2003, 68, 1701-1707 and Org. Lett. 2003, 5, 1273-75, present preparations of enantiomerically enriched phospholanes. Here too, the conversion into the phospholane is brought about using phenolphosphine or a lithiated bistrimethylsilylphosphide.
It was an object of the present invention to provide a further process for preparing the abovementioned phospholanes and enantiomerically enriched ligands. In particular, the process should be economical on|an industrial scale from both economic and ecological points of view. Very particular value should be attached to a process which starts out from materials which are readily available commercially and uses reagents which can be handled relatively unproblematically.
Such a process is proposed in the claims. Claim 1 describes a process for preparing the desired ligand systems. The dependent subordinate Cairns 2 to 13 are directed at preferred embodiments of the process of the invention.
Carrying out a process for preparing enantiomerically enriched compounds of the general formula (I) ,


WO 2005/049629 PCT/EP2004/012279
3
where
* indicates a stereogenic centre,
R1 and R4 are each, independently of one another
(C1-C8)-alkyl, HO-(C1-C8)-alkyl, (C1-C8) -alkoxy,
(C2-C8)-alkoxyalkyl, (C6-C18)-aryl, (C7-C19)-aralkyl,
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl,
(C1-C8)-alkyl-(C3-C8)-cycloalkyl,
(C3-C8)-cycloalkyl- (C1-C8)-alkyl,
R2 and R3 are each, independently of one another, H, (C1-C8) -alkyl, HO-(C1-C8)-alkyl, (C1-C8) -alkoxy, (C2-C8)-alkoxyalkyl, (C6-C18)-aryl, (C7-C19)-aralkyl, (C1-C8)-alkyl-(C6-C18)-aryl, (C3-C8)-cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl, (C3-C8) -cycloalkyl- (C1-C8) -alkyl,
A is a C2 bridge in which two carbon atoms have sp2
hybridization, starting from compounds of the general
formula (II),

where
R1 to R4 can be as defined above,
M is an alkali metal or a trimethylsilyl group, and
reacting these with compounds of the general formula (III),
X-A-X (III)
where
A is as defined above and
the radicals X are each, independently of one anotheir, a
nucleofugic leaving group, and preparing the compounds of
the general formula (II) by reacting compounds of the
general formula (IV) ,

WO 2005/049629
PCT/EP2004/012279

4

where
R1 to R4 are as defined above and
the radicals Y are each, independently of one another, a
nucleofugic leaving group,
with compounds of the general formula (V),
M2P-Aryl (V)
where
M is. an alkali metal and Aryl is a (C6-C18) -aryl or ( (C1-C8)-alkyl)1-3-(C6-C18)-aryl radical, and subsequently with an alkali metal and additionally, if appropriate, with trimethylsilyl chloride,
with the compounds of the formula (V) being obtained by reaction of compounds of the general formula (VI) ,
Hal2P-Aryl (VI)
where
Aryl is as defined above,
with an alkali metal, enables the ligand systems in
question to be obtained simply and particularly
advantageously according to the invention. It was
particularly suprising that the procedure described
achieves a relatively good increase in yield, which was not
to have been expected from the prior art.

WO 2005/049629 PCT/EP2004/012279
5
The process described above is preferably applied to compounds in which A is a radical from the group consisting of

where
R is H, (C1-C8)-alkyl, (C6-C18)-aryl, (C7-C19) -aralkyl,
(C1-C8)-alkyl-(C6-C18)-aryl, (C3-C8) -cycloalkyl,
(C1-C8)-alkyl-(C3-C8)-cycloalkyl,
(C3-C8)-cycloalkyl-(C1-C8)-alkyl, and Q is O, NH, NR. Q in these formulae is particularly preferably oxygen or NR, with R being able to be(C1-C8) -alkyl, (C6-C18) -aryl, benzyl. Especially preferred radicals R are methyl, ethyl, propyl , isopropyl, tert-butyl, phenyl, naphthyl, fluorenyl, benzyl.
Preference is likewise given to using compounds of the formula (IV) in which R2 and R3 are each H and RF and R4 are each, independently of one another, (C1-C8) -alkyl, HO— (C1-C8)-alkyl, (C2-C8)-alkoxyalkyl.
Preference is also given to using compounds of the genera 1 formula (III) or (IV) in which X or Y is selected from the group consisting of halogen, Otos (p-toluenesulfonate) , OMes (methylsulfonate), triflate (trifluoroacetate) , p-nitrobenzenesulfonate (nosylate, ONs) in the process of the invention.

WO 2005/049629 PCT/EP2004/012279
6
Particular preference is likewise given to using compounds of the general formula (VII) or (VIII) , for compounds of general formular (IV)

where
the radicals Y are selected independently from the group consisting of- halogen, OTos, OMes, triflate, nosylate, R1 and R4 are each, independently of one another, (C1-C8)-alkyl, HO- (C1-C8) -alkyl, (C2-C8) -alkoxyalkyl, (C6-C18)-aryl, (C7-C19) -aralkyl, (C1-C8)-alkyl-(C6-C18)-aryl, (C3-C8)-cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl, (C3-C8)-cycloalkyl-(d-C8)-alkyl,
the radicals R' are each, independently of one another, H, (C1-C8) -alkyl, HO- (C1-C8) -alkyl, (C6-C18) -aryl, (C7-C19) -aralkyl, (C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl, (C1-C8)-alkyl-(C3-C8)-cycloalkyl, (C3-C8) -cycloalkyl- (C1-C8) -alkyl.
Very particular preference is given to compounds of the formula (VII) or (VIII) in which R' is H, methyl, ethyl, propyl, isopropyl, tert-butyl, phenyl, and R1 and R4 are each methyl, ethyl, propyl, isopropyl, tert-butyl, phenyl.
In principle, all elements of main group 1 of the Periodic Table can be employed as alkali metals . Preference is here given to lithium, sodium and potassium, with lithium being especially preferred as the metal to be used.
The solvents to be used for the individual steps of the process can be selected by a person skilled in the art on the basis of his general technical knowledge. The solvents should be solvents which do not if at all possible, promote

WO 2005/049629 PCT/EP2004/012279
7
any secondary reactions and are themselves inert under the reaction conditions. The reaction of compounds of the general formula (VI) with alkali metals is preferably carried out in an aprotic polar solvent. Very particular preference is here given to ethers such as THF, diethyl ether, dioxane, DME or DEE.
The temperature window within which the reaction according to the invention is carried out can likewise be selected freely by a person skilled in the art. Here, a person skilled in the art will be guided by efficiency factors such as space-time yield, energy costs and by-products spectra and set a temperature which helps to ensure an optimal reaction. The reaction of the compound (IV) with the compound (V) is preferably carried out at a temperature of from -50°C to +100°C, more preferably from -30°C to +80°C and particularly preferably from -25°C to +40°C. The reaction of compounds of the general formula (VI) with alkali metals can, on the other hand, be carried, out at temperatures of from -25°C to +40°C, preferably from -15°C to +30°C and particularly preferably from -10°C to +10°C.
In a further, preferred embodiment of the present process, the reactions of (VI) with alkali metals to form (V) and subsequently with (IV) and also the further reaction of the products obtained to form (III) and finally with (II) to form (I) can be carried out in a single vessel. Thus, the entire reaction can be carried out in a simple fashion as a. one-pot synthesis.
The present process thus offers a further very decisive advantage over the synthetic routes disclosed in the prior art. Furthermore, the choice of starting substances means that no strong, difficult-to-handle bases, e.g. alkyllithium compounds, have to be used in the synthesis. As a result, the present route can be carried out on an industrial scale without costly safety equipment and

WO 2005/049629 PCT/EP2004/012279
8
precautions, which in the final analysis helps make the products cheaper and thus economically more attractive.
The present invention is generally carried out as follows:
In step 1, the compounds of the formula (IV) are prepared as shown by way of example in the following scheme.

The compounds of the general formula (V) are subsequently prepared and are then reacted with the compounds of the formula (IV) .

After this, the further synthesis after
phenyl/lithium/trimethylsilyl exchange can be completed by reaction of the compounds of the formula (III) with those of the formula (II) .


WO 2005/049629 PCT/EP2004/012279
9
The overall yield can reach values of > 60%, preferably
> 65% and very particularly preferably > 70%, starting from
compounds of the formula (VI).
For the purposes of the present invention, (C1-C8) -alkyl is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl or octyl, including all bonding isomers.
The term (C1-C8) -alkoxy refers to (C1-C8)-alkyl radicals which are bound via an oxygen atom to the respective molecule.
The term (C1-C8) -alkoxyalkyl refers to (C1-C8) -alkyl radicals which have an oxygen atom in their chain.
The term (C3-C8)-cycloalkyl encompasses cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl radicals, etc.
For the purposes of the present invention, a (C6-C18) -aryl radical is an aromatic radical having from 6 to 18 carbon atoms. In particular, such radicals include phenyl, naphthyl, anthryl, phenanthryl, biphenyl radicals.
A (C7-C19)-aralkyl radical is a (C6-C18) -aryl radical bound via a (C1-C8) -alkyl radical to the molecule.
Nucleofugic leaving groups are, in particular: halogen, Otosyl (OTos), Omesyl (OMes), triflate, nosylate.
Possible halogens (Hal) are chlorine, bromine and iodine.
For the purposes of the invention, the term enantiomerically enriched means that the proportion of one enantiomer in the mixture with its opposite enantiomer is in a range from >50% and <100%.

WO 2005/049629 PCT/EP2004/012279
10
The structures shown encompass all possible diastereomers and the enantiomers (R, S form) coming under the respective diastereomer.
The references cited are hereby incorporated by reference into the disclosure of the present invention.

WO 2005/049629 PCT/EP2004/012279
11
Examples :
The following examples serve to illustrate the invention. They do not in any way constitute a restriction.
Example 1: (2S,5S)-2,5-Hexanediol bismesylate Variant 1:
60g of (2S,5S)-2,5-hexanediol are dissolved in 400ml of dichloromethane and 177 ml of triethylamine and the solution is cooled to 0°C. The methanesulfonyl chloride is added dropwise as a solution in 50 ml of dichl oromethane, with the temperature being kept below 30°C. The reaction solution is stirred at room temperature for 60 minutes and subsequently hydrolyzed with 200 ml of water. The phases are separated and the aqueous phase is extracted once with dichloromethane. The organic phase is washed with saturated sodium chloride solution, dried and the solvent is removed under reduced pressure.
Yield: 138.5g; 99%
Variant 2:
120g of (2S,5S)-2,5-hexanediol are suspended in 450 ml of toluene and 3 53.5 ml of triethylamine and the mixture is cooled to 5°C. A solution of 255.9 ml of methanesulfonyl chloride in 50 ml of toluene is added dropwise to this suspension, with the temperature being kept below 30°C. The reaction solution is stirred at room temperature for 1 hour and subsequently hydrolyzed with 250 ml of water. The phases are separated and the aqueous phase is extracted once with toluene. The organic phase is washed with saturated sodium chloride solution and subsequently dried over magnesium sulfate. The solvent is removed under reduced pressure.

WO 2005/049629 PCT/EP2004/012279
12
Yield: 256.7g; 92%
Example 2: (2R,5R)-2,5-Dimethyl-1-phenylphospholane Variant 1:
44.4 g of lithium are suspended in 400 ml of THF and the mixture is cooled to 0°C. 143.2 g of
dichlorophenylphosphine (dissolved in 200 ml of THF) are slowly added dropwise to this reaction mixture, with the temperature being kept below 3 0°C. The orange suspension is stirred for 1 hour and the THF is subsequently removed under reduced pressure. The residue is taken up in 600 ml of dimethoxyethane and refluxed for 5 hours. After cooling to room temperature, the suspension is transferred to a further reaction vessel, with the residual lithium remaining in the first vessel. The suspension is cooled to -20°C and 195 g of (2S, 5S) -2,5-hexanediol bismes,ylate (dissolved in 200 ml of toluene) are subsequently added, with the temperature being kept below 5°C. The reaction mixture is stirred at room temperature for a further 8 hours and the solvent is subsequently removed under reduced pressure. The residue is taken up in 500 ml of heptane, the mixture is filtered and the solid is washed twice with 300 ml each time of heptane. The heptane is removed under reduced pressure and the crude product is subsequently distilled (87-89°C / 1 mbar)
Yield: 97.1 g; 71%
1H-NMR (C6D6) :5 = 0.70 (dd 3H), 1.11-1.30 (m, 2H) , 1.20 (dd, 3H), 1.65 (m 1H), 2.00-2.45 (m, 3H), 7.50-7.30 (5H) ppm.
31P-NMR (C6D6):5 = 11.1 ppm.

WO 2005/049629 PCT/EP2004/012279
13
Variant 2: (comparison)
375 ml of methyllithium (1.6 M in ether) are added at -20°C to a solution of 32 g of phenylphosphine in 3 00 ml of THF. After the addition, the solution is warmed to room temperature and stirred for 1 hour. 72.5 g of (2S,5S)-2,5-hexanediol bismesylate are dissolved in 75 ml of THF and added to the reaction solution at -20°C. The reaction mixture is warmed to room temperature and stirred for 16 hours. The solvent is subsequently removed under reduced pressure and the residue is taken up in 400 ml of heptane. The reaction mixture is filtered and the residue is washed with 200 ml of heptane. The solvent is removed under reduced pressure and the product is distilled under reduced pressure (72-75°C / 0.5 mbar).
Yield: 26.5 g; 52%
Variant 3: (comparison)
113 ml of butyllithium (1.6 M in hexane) are added at -30°C to a solution of 99 g of phenylphosphine (10% strength in hexane) in 3 00 ml of THF. After the addition, the solution is warmed to room temperature and stirred for 1 hour. 22.5 g of (2S, 5S) -2, 5-hexanediol bismesylate are dissolved in 50 ml of THF and added to the reaction solution at -30°C. The reaction mixture is warmed to room temperature and stirred for 16 hours. The solvent is subsequently removed under reduced pressure and the residue is taken up in 100 ml of heptane. The reaction mixture is filtered and the residue is washed with 100 ml of heptane. The solvent is removed under reduced pressure and the product is distilled under reduced pressure (69-75°C / 0.5 mbar).
Yield: 11.65g; 67%

WO 2005/049629 PCT/EP2004/012279
14
Example 3: (2R, 5R)-2, 5-Dimethyl-l-trimethylsilylphospholane
1.67 g of lithium are suspended in 60 ml of THF. 7.75 g of (2S, 5S) -2, 5-dimethyl-1-phenylphospholane (dissolved in 10 ml of THF) are added dropwise at 0°C to this suspension. The reaction solution is stirred at room temperature for 1 hour and subsequently transferred to a further reaction vessel, with the lithium remaining in the first vessel. 11.2 ml of chlorotrimethylsilane (dissolved in 10 ml of THF) are added to this reaction mixture. After 2 hours, the solvent is removed under reduced pressure and the crude product is distilled under reduced pressure (80-90°C / 30mbar).
Yield: 5.15 g; 68%
1H-NMR (CDC13):d = 0.20 (d, 9H) , 1.25-1.15 (m, 6H) , 2.54-1.20 (m, 6H) ppm.
31P-NMR (CDC13): d = -54.4 ppm.
Example 4: 2,3-Bis[(R,R)-2,5-dimethylphospholanyl]maleic anhydride
4.71g of (2R,5R)-2,5-dimethyl-l-trimethylsilylphospholane (dissolved in 5 ml of ether) are added at 0°C to a solution of 2.09 g of dichloromaleic anhydride in 20 ml of ether and the mixture is stirred at this temperature for a further 15 minutes. After a further 3 0 minutes at room temperature, the solution is cooled to -78°C. The product crystallizes as brown crystals. The crystals are filtered off and dried under reduced pressure.
Yield: 3.56 g; 87%
1H-NMR (CDC13): d = 1.06 (dd, 6H), 1.22 (dd, 6H), 2.49-1.25 (m, 12H), 3.32 (m, 2H) ppm.

WO 2005/049629 PCT/EP2004/012279
15
31P-NMR (CDC13): d = -2.2 ppm.
Example 5: {2,3-Bis[(R,R) -2 , 5-dimethylphospholanyl]maleic anhydride} (cyclooctadiene) rhodium (I) tetrafluoroborate
1.90 g of 2,3-bis [ (R,R)-2, 5-dimethylphospholanyl]maleic anhydride are dissolved in 15 ml of THF and the solution is cooled to -20°C. 2.40 g of [Rh(COD)2]BF4 (suspended in 20 ml of THF) are slowly added to the solution. The solution is warmed to room temperature and stirred for a further 90 minutes. 25 ml of ether are added to the reaction solution and the product is subsequently filtered off. The crystals are washed with 25 ml of ether and dried under reduced pressure.
Yield: 3.51 g; 97%
1H-NMR (Aceton-d6) : d = 1.23 (dd, 6H) , 1.57 (dd, 6H) , 2.67-
1.50 (ml8H),.3.07 (m 2H) , 5.15 (s, 2H) , 5.85 (s, 2H) ppm.
31P-NMR (Aceton-d6) : d = 63.8 (d, J =15lHz) ppm.
Example 6: 2, 3-Bis [ (R, R)-2 , 5-dimethylphospholanyl]maleimide
A solution of 4.50 g of (2R, 5R) -2, 5-dimethyl-l-trimethylsilylphospholane (dissolved in 5 ml of THF) is added dropwise at 0°C to a solution of 2.70 g of N-methyl-2,.3-dibromomaleimide in 10 ml of THF and the mixture is stirred for a further one hour. The solvent and all volatile components are removed under reduced pressure. The product is isolated as a red-brown oil.
Yield: 3.20g (94%)

WO 2005/049629 PCT/EP2004/012279
16
1H-NMR (CDC13): d = 1.05 (dd, 6H) , 1.22 (dd, 6H) , 1.78 (m, 2H) , 2.05 (m, 2H) , 2.26 (m, 2H), 2.42 (m, 2H), 2.98 (d, 3H), 3.32 (m, 2H) ppm.
31P-NMR (CDC13): d = -4.9ppm.

WO 2005/049629 PCT/EP2004/0I2279
17
Claims:
1. Process for preparing enantiomerically enriched compounds of the general formula (I) ,

where
* indicates a stereogenic centre,
R1 and R4 are each, independently of one another (C1-C8)-alkyl, HO-(C1-C8)-alkyl, (C1-C8)-alkoxy, (C2-C8)-alkoxyalkyl, (C6-C18) -aryl, (C7-C19) -aralkyl, (C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl, (C3-C8) -cycloalkyl- (C1-C8) -alkyl,
R2 and R3 are each, independently of one another, H, (C1-C8) -alkyl, HO-(C1-C8)-alkyl, (C1-C8)-alkoxy, (C2-C8)-alkoxyalkyl, (C6-C18)-aryl, (C7-C19)-aralkyl, (C1-C8)-alkyl-(C6-C18)-aryl, (C3-C8)-cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl,
A is a C2 bridge in which two carbon atoms have sp2
hybridization,
by reacting compounds of the general formula (II),

where
R1 to R4 can be as defined above,
M is an alkali metal or a trimethylsilyl group,

WO 2005/049629 PCT/EP2004/012279
18
with compounds of the general formula (III),
X-A-X (III)
where
A is as defined above and
the radicals X are each, independently of one another,
a nucleofugic leaving group,
characterized in that the compounds of the general
formula (II) are prepared by reacting compounds of the
general formula (IV),

where
R1 to R4 are as defined above and
the radicals Y are each, independently of one another,
a nucleofugic leaving group,
with compounds of the general formula (V),
M2P-Aryl (V)
where
M is an alkali metal and Aryl is a (C6-C18) -aryl or ( (C1-C8)-alkyl)1-3-(C6-C18)-aryl radical, and subsequently with an alkali metal and, if appropriate, additionally with trimethylsilyl chloride, with the compounds of the formula (V) being obtained by reaction of compounds of the general formula (VI),
Hal2P-Aryl (VI)

WO 2005/049629 PCT/EP2004/012279
19
where
Aryl is as defined above,
with an alkali metal.
2. Process according to Claim 1, characterized in that A is a radical from the group consisting of

where
R is H, (C1-C8)-alkYl, (C6-C18)-aryl, (C7-C19) -aralkyl, (C1-C8)-alkyl-(C6-C18)-aryl, (c3-C8)-cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, Q is O, NH, NR.
3. Process according to Claim 2,
characterized in that
Q is oxygen or NR, where R can be (C1-C8)-alkyl, (C6-C18)-aryl, benzyl.
4. Process according to Claim 3,
characterized in that
Q is oxygen or NR, where R can be methyl, ethyl, propyl, isopropyl, tert-butyl, phenyl, naphthyl, fluorenyl, benzyl.
5. Process according to one or more of Claims 1 to 4,
characterized in that
compounds of the formula (IV) in which R2 and R3 are each H and R1 and R4 are each, independently of one another, (C1-C8)-alkyl, HO-(C1-C8)-alkyl, (C2-C8) -alkoxyalkyl are used.

WO 2005/049629 PCT/EP2004/012279
20
6. Process according to one or more of Claims 1 to 5,
characterized in that
compounds of the general formula (III) or (IV) in which X or Y is selected from the group consisting of halogen, OTos, OMes, triflate, nosylate, are used.
7. Process according to one or more of Claims 1 to 6,
characterized in that
compounds of the general formula (VII) or (VIII),

where
the radicals Y are selected independently from the
group consisting of halogen, OTos, OMes, triflate,
nosylate,
R1 and R4 are each, independently of one another,
(C1-C8)-alkyl, HO- (C1-C8) -alkyl, (C2-C8)-alkoxyalkyl,
(C6-C18)-aryl, (C7-C19) -aralkyl,
(C1-C8)-alkyl-(C6-C18)-aryl, (C3-C8) -cycloalkyl,
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,
(C3-C8) -cycloalkyl- (C1-C8) -alkyl,
the radicals R' are each, independently of one
another,
H, (C1-C8)-alkyl, HO-(C1-C8)-alkyl, (C6-C18)-aryl,
(C7-C19) -aralkyl, (C1-C8) -alkyl- (C6-C18) -aryl,
(C3-C8)-cycloalkyl, (C1-C8)-alkyl-(C3-C8)-cycloalkyl,
(C3-C8) -cycloalkyl- (C1-C8) -alkyl,
are used for compounds of general formular (IV) .
8. Process according to Claim 7, characterized in that R' is H, methyl, ethyl, propyl, isopropyl, tert-butyl,

WO 2005/049629 PCT/EP2004/012279
21
phenyl, and
R1 and R4 are each methyl, ethyl, propyl, isopropyl,
tert-butyl, phenyl.
9. Process according to one or more of the Claims 1 to 8,
characterized in that
the alkali metal used is lithium.
10. Process according to one or more of Claims 1 to 9,
characterized in that
the reaction of compounds of the general formula (VI) with alkali metals is carried out in an aprotic polar solvent.
11. Process according to one or more of Claims 1 to 10,
characterized in that
the reaction of the compound (IV) with the compound (V) is carried out at a temperature of from -25°C to +40°C.
12. Process according to one or more of Claims 1 to 6,
characterized in that
the reaction of compounds of the general formula (VI) with alkali metals is carried out at temperatures of -10°C to +10°C.
13. Process according to Claim 1,
characterized in that
the reaction is carried out in a one-pot variant.
The present invention is directed at a process for preparing enantiomerically enriched compounds of the general formula (I). Compounds of the type shown are employed in catalyst systems.

Documents

Application Documents

# Name Date
1 1077-KOLNP-2006-ABANDONED LETTER.pdf 2016-10-04
1 abstract-01077-kolnp-2006.jpg 2011-10-07
2 1077-KOLNP-2006-FIRST EXAMINATION REPORT.pdf 2016-10-04
2 01077-kolnp-2006-priority document.pdf 2011-10-07
3 1077-KOLNP-2006_EXAMREPORT.pdf 2016-06-30
3 01077-kolnp-2006-international search authority report-1.1.pdf 2011-10-07
4 01077-kolnp-2006-description(complete)-1.1.pdf 2011-10-07
4 01077-kolnp-2006 abstract.pdf 2011-10-07
5 01077-kolnp-2006-correspondence others-1.1.pdf 2011-10-07
5 01077-kolnp-2006 assignment.pdf 2011-10-07
6 01077-kolnp-2006-claims-1.1.pdf 2011-10-07
6 01077-kolnp-2006 claims.pdf 2011-10-07
7 01077-kolnp-2006-abstract-1.1.pdf 2011-10-07
7 01077-kolnp-2006 correspondence others.pdf 2011-10-07
8 01077-kolnp-2006 pct form.pdf 2011-10-07
8 01077-kolnp-2006 description (complete).pdf 2011-10-07
9 01077-kolnp-2006 international search authority report.pdf 2011-10-07
9 01077-kolnp-2006 form-1.pdf 2011-10-07
10 01077-kolnp-2006 form-2.pdf 2011-10-07
10 01077-kolnp-2006 international publication.pdf 2011-10-07
11 01077-kolnp-2006 form-3.pdf 2011-10-07
11 01077-kolnp-2006 form-5.pdf 2011-10-07
12 01077-kolnp-2006 form-3.pdf 2011-10-07
12 01077-kolnp-2006 form-5.pdf 2011-10-07
13 01077-kolnp-2006 form-2.pdf 2011-10-07
13 01077-kolnp-2006 international publication.pdf 2011-10-07
14 01077-kolnp-2006 form-1.pdf 2011-10-07
14 01077-kolnp-2006 international search authority report.pdf 2011-10-07
15 01077-kolnp-2006 description (complete).pdf 2011-10-07
15 01077-kolnp-2006 pct form.pdf 2011-10-07
16 01077-kolnp-2006 correspondence others.pdf 2011-10-07
16 01077-kolnp-2006-abstract-1.1.pdf 2011-10-07
17 01077-kolnp-2006 claims.pdf 2011-10-07
17 01077-kolnp-2006-claims-1.1.pdf 2011-10-07
18 01077-kolnp-2006 assignment.pdf 2011-10-07
18 01077-kolnp-2006-correspondence others-1.1.pdf 2011-10-07
19 01077-kolnp-2006-description(complete)-1.1.pdf 2011-10-07
19 01077-kolnp-2006 abstract.pdf 2011-10-07
20 1077-KOLNP-2006_EXAMREPORT.pdf 2016-06-30
20 01077-kolnp-2006-international search authority report-1.1.pdf 2011-10-07
21 1077-KOLNP-2006-FIRST EXAMINATION REPORT.pdf 2016-10-04
21 01077-kolnp-2006-priority document.pdf 2011-10-07
22 abstract-01077-kolnp-2006.jpg 2011-10-07
22 1077-KOLNP-2006-ABANDONED LETTER.pdf 2016-10-04